Importancia de la predicción del perfil ADMET en bases de datos de productos naturales Importance of ADMET profile prediction in natural product databases
Main Article Content
Resumen
Los productos naturales (PNs) son la mayor fuente de moléculas bioactivas con propiedades terapéuticas. Actualmente, existen bases de datos moleculares que reúnen miles de PNs, a partir de las cuales es posible seleccionar aquellos con el mejor perfil de absorción, distribución, metabolismo, excreción y toxicidad (ADMET), lo que incrementa en gran medida sus probabilidades de éxito en fases clínicas. En este artículo se discute la relevancia de predecir el perfil ADMET en etapas tempranas del desarrollo de fármacos, especialmente a partir de bases de datos de PNs. Se presentan diecinueve servidores web de acceso libre que permiten llevar a cabo estas predicciones y se exponen algunos de los parámetros ADMET más relevantes que pueden evaluarse mediante dichas herramientas.
Article Details

Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
Citas
Arun Kumar Ms, Rajesh M, & Subramanian L. (2023). Solubility enhancement techniques: A comprehensive review. World Journal of Biology Pharmacy and Health Sciences, 13(3), 414–149. https://doi.org/10.30574/wjbphs.2023.13.3.0125
Avdeef, A. (2005). The rise of PAMPA. Expert Opinion on Drug Metabolism & Toxicology, 1(2), 325–342. https://doi.org/10.1517/17425255.1.2.325
Azman, M., Sabri, A. H., Anjani, Q. K., Mustaffa, M. F., & Hamid, K. A. (2022). Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals (Basel, Switzerland), 15(8). https://doi.org/10.3390/ph15080975
Bergazin, T. D., Tielker, N., Zhang, Y., Mao, J., Gunner, M. R., Francisco, K., Ballatore, C., Kast, S. M., & Mobley, D. L. (2021). Evaluation of log P, pKa, and log D predictions from the SAMPL7 blind challenge. Journal of Computer-Aided Molecular Design, 35(7), 771–802. https://doi.org/10.1007/s10822-021-00397-3
Brown. (2009). Quimica: La Ciencia Central, 11/ed. (First Edition). Pearson Education.
Chandrasekhar, V., Rajan, K., Kanakam, S. R. S., Sharma, N., Weißenborn, V., Schaub, J., & Steinbeck, C. (2025). COCONUT 2.0: a comprehensive overhaul and curation of the collection of open natural products database. Nucleic Acids Research, 53(D1), D634–D643. https://doi.org/10.1093/nar/gkae1063
Chang, C.-C., Hsu, H.-J., Wu, T.-Y., & Liou, J.-W. (2022). Computer-aided discovery, design, and investigation of COVID-19 therapeutics. Tzu Chi Medical Journal, 34(3), 276–286. https://doi.org/10.4103/tcmj.tcmj_318_21
Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X. (2020). Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review. Micromachines, 11(4). https://doi.org/10.3390/mi11040381
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
Di, L., Keefer, C., Scott, D. O., Strelevitz, T. J., Chang, G., Bi, Y.-A., Lai, Y., Duckworth, J., Fenner, K., Troutman, M. D., & Obach, R. S. (2012). Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. European Journal of Medicinal Chemistry, 57, 441–448. https://doi.org/10.1016/j.ejmech.2012.06.043
Dowden, H., & Munro, J. (2019). Trends in clinical success rates and therapeutic focus. Nature Reviews. Drug Discovery, 18(7), 495-496 (GSM 2024 h5-index 136). https://doi.org/10.1038/d41573-019-00074-z
Duan, F.-L., Duan, C.-B., Xu, H.-L., Zhao, X.-Y., Sukhbaatar, O., Gao, J., Zhang, M.-Z., Zhang, W.-H., & Gu, Y.-C. (2024). AI-driven drug discovery from natural products. Advanced Agrochem, 3(3), 185–187. https://doi.org/10.1016/j.aac.2024.06.003
Dulsat, J., López-Nieto, B., Estrada-Tejedor, R., & Borrell, J. I. (2023). Evaluation of free online ADMET tools for academic or small biotech environments. Molecules, 28(2). https://doi.org/10.3390/molecules28020776
Fu, L., Shi, S., Yi, J., Wang, N., He, Y., Wu, Z., Peng, J., Deng, Y., Wang, W., Wu, C., Lyu, A., Zeng, X., Zhao, W., Hou, T., & Cao, D. (2024). ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Research, 52(W1), W422–W431. https://doi.org/10.1093/nar/gkae236
Gallo, K., Kemmler, E., Goede, A., Becker, F., Dunkel, M., Preissner, R., & Banerjee, P. (2023). SuperNatural 3.0-a database of natural products and natural product-based derivatives. Nucleic Acids Research, 51(D1), D654–D659. https://doi.org/10.1093/nar/gkac1008
Gangadevi, S., Badavath, V. N., Thakur, A., Yin, N., De Jonghe, S., Acevedo, O., Jochmans, D., Leyssen, P., Wang, K., Neyts, J., Yujie, T., & Blum, G. (2021). Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19. The Journal of Physical Chemistry Letters, 12(7), 1793–1802. https://doi.org/10.1021/acs.jpclett.0c03119
Gangwal, A., & Lavecchia, A. (2025). Artificial intelligence in natural product drug discovery: current applications and future perspectives. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01257
Gao, H., Dai, R., & Su, R. (2023). Computer-aided drug design for the pain-like protease (PLpro) inhibitors against SARS-CoV-2. Biomedicine & Pharmacotherapy (Biomedecine & Pharmacotherapie), 159, 114247. https://doi.org/10.1016/j.biopha.2023.114247
García-Sosa, A. T., Oja, M., Hetényi, C., & Maran, U. (2012). DrugLogit: logistic discrimination between drugs and nondrugs including disease-specificity by assigning probabilities based on molecular properties. Journal of Chemical Information and Modeling, 52(8), 2165–2180. https://doi.org/10.1021/ci200587h
Gómez-García, A., Acuña Jiménez, D. A., Zamora, W. J., Barazorda-Ccahuana, H. L., Chávez-Fumagalli, M. Á., Valli, M., Andricopulo, A. D., Bolzani, V. da S., Olmedo, D. A., Solís, P. N., Núñez, M. J., Rodríguez Pérez, J. R., Valencia Sánchez, H. A., Cortés Hernández, H. F., Mosquera Martinez, O. M., & Medina-Franco, J. L. (2024). Latin american natural product database (lanapdb): an update. Journal of Chemical Information and Modeling, 64(22), 8495–8509. https://doi.org/10.1021/acs.jcim.4c01560
Harrison, R. K. (2016). Phase II and phase III failures: 2013-2015. Nature Reviews. Drug Discovery, 15(12), 817–818. https://doi.org/10.1038/nrd.2016.184
Kim, K.-S., & Kim, E.-J. (2005). The phenothiazine drugs inhibit hERG potassium channels. Drug and Chemical Toxicology, 28(3), 303–313. https://doi.org/10.1081/dct-200064482
Kim, M. T., Sedykh, A., Chakravarti, S. K., Saiakhov, R. D., & Zhu, H. (2014). Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches. Pharmaceutical Research, 31(4), 1002–1014. https://doi.org/10.1007/s11095-013-1222-1
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2025). PubChem 2025 update. Nucleic Acids Research, 53(D1), D1516–D1525. https://doi.org/10.1093/nar/gkae1059
Label Review Manual Chapter 7: Precautionary Statements. (n.d.). U.S. Environmental Protection Agency. Retrieved April 9, 2025, from https://www.epa.gov/sites/default/files/2015-03/documents/chap-07-jul-2014.pdf
Lagorce, D., Bouslama, L., Becot, J., Miteva, M. A., & Villoutreix, B. O. (2017). FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics, 33(22), 3658–3660. https://doi.org/10.1093/bioinformatics/btx491
Lee, S. K. (2004). preADMET. https://preadmet.webservice.bmdrc.org/
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
Liu, X., Wright, M., & Hop, C. E. C. A. (2014). Rational use of plasma protein and tissue binding data in drug design. Journal of Medicinal Chemistry, 57(20), 8238–8248. https://doi.org/10.1021/jm5007935
Lv, Q., Chen, G., He, H., Yang, Z., Zhao, L., Zhang, K., & Chen, C. Y.-C. (2023). TCMBank-the largest TCM database provides deep learning-based Chinese-Western medicine exclusion prediction. Signal Transduction and Targeted Therapy, 8(1), 127. https://doi.org/10.1038/s41392-023-01339-1
Mansoor, A., & Mahabadi, N. (2025). Volume of Distribution. In StatPearls. StatPearls Publishing.
Martins, I. F., Teixeira, A. L., Pinheiro, L., & Falcao, A. O. (2012). A Bayesian approach to in silico blood-brain barrier penetration modeling. Journal of Chemical Information and Modeling, 52(6), 1686–1697. https://doi.org/10.1021/ci300124c
Maunz, A., Gütlein, M., Rautenberg, M., Vorgrimmler, D., Gebele, D., & Helma, C. (2013). lazar: a modular predictive toxicology framework. Frontiers in Pharmacology, 4, 38. https://doi.org/10.3389/fphar.2013.00038
McCann, J., Choi, E., Yamasaki, E., & Ames, B. N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proceedings of the National Academy of Sciences of the United States of America, 72(12), 5135–5139. https://doi.org/10.1073/pnas.72.12.5135
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008). Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacological Reviews, 60(2), 196–209. https://doi.org/10.1124/pr.107.07109
Mishra, N. K., Agarwal, S., & Raghava, G. P. (2010). Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule. BMC Pharmacology, 10, 8. https://doi.org/10.1186/1471-2210-10-8
Mohanraj, K., Karthikeyan, B. S., Vivek-Ananth, R. P., Chand, R. P. B., Aparna, S. R., Mangalapandi, P., & Samal, A. (2018). IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. Scientific Reports, 8(1), 4329. https://doi.org/10.1038/s41598-018-22631-z
Morris-Schaffer, K., & McCoy, M. J. (2021). A review of the ld50 and its current role in hazard communication. ACS Chemical Health & Safety, 28(1), 25–33. https://doi.org/10.1021/acs.chas.0c00096
Myung, Y., de Sá, A. G. C., & Ascher, D. B. (2024). Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Research, 52(W1), W469–W475. https://doi.org/10.1093/nar/gkae254
Newman, D. J., & Cragg, G. M. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
Orange Book Preface. (n.d.). FDA. Retrieved March 10, 2025, from https://www.fda.gov/drugs/development-approval-process-drugs/orange-book-preface#endnote-8
Panigrahi, B. S., Dogra, A., Sivakumar, K., Diwakar, S., Bagal, Y. S., & Upadhye, M. (2024). Big data and AI in natural product drug discovery: uncovering hidden medicinal chemistry gems. 2024 Ninth International Conference on Science Technology Engineering and Mathematics (ICONSTEM), 1–5. https://doi.org/10.1109/ICONSTEM60960.2024.10568743
Rudik, A., Dmitriev, A., Lagunin, A., Filimonov, D., & Poroikov, V. (2015). SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds. Bioinformatics, 31(12), 2046–2048. https://doi.org/10.1093/bioinformatics/btv087
Rudik, A. V., Dmitriev, A. V., Lagunin, A. A., Filimonov, D. A., & Poroikov, V. V. (2023). MetaTox 2.0: Estimating the Biological Activity Spectra of Drug-like Compounds Taking into Account Probable Biotransformations. ACS Omega, 8(48), 45774–45778. https://doi.org/10.1021/acsomega.3c06119
Rydberg, P., Gloriam, D. E., & Olsen, L. (2010). The SMARTCyp cytochrome P450 metabolism prediction server. Bioinformatics, 26(23), 2988–2989. https://doi.org/10.1093/bioinformatics/btq584
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021). Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. European Journal of Medicinal Chemistry, 224, 113705. https://doi.org/10.1016/j.ejmech.2021.113705
Saldívar-González, F. I., Aldas-Bulos, V. D., Medina-Franco, J. L., & Plisson, F. (2022). Natural product drug discovery in the artificial intelligence era. Chemical Science (Royal Society of Chemistry : 2010), 13(6), 1526–1546. https://doi.org/10.1039/d1sc04471k
Schneider, M. R., Oelgeschlaeger, M., Burgdorf, T., van Meer, P., Theunissen, P., Kienhuis, A. S., Piersma, A. H., & Vandebriel, R. J. (2021). Applicability of organ-on-chip systems in toxicology and pharmacology. Critical Reviews in Toxicology, 51(6), 540–554. https://doi.org/10.1080/10408444.2021.1953439
Schyman, P., Liu, R., Desai, V., & Wallqvist, A. (2017). vnn web server for ADMET predictions. Frontiers in Pharmacology, 8, 889. https://doi.org/10.3389/fphar.2017.00889
Simoben, C. V., Qaseem, A., Moumbock, A. F. A., Telukunta, K. K., Günther, S., Sippl, W., & Ntie-Kang, F. (2020). Pharmacoinformatic Investigation of Medicinal Plants from East Africa. Molecular Informatics, 39(11), e2000163. https://doi.org/10.1002/minf.202000163
Siva Kumar, B., Anuragh, S., Kammala, A. K., & Ilango, K. (2022). Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme. Life (Basel, Switzerland), 12(2). https://doi.org/10.3390/life12020315
Smith, D. A., Beaumont, K., Maurer, T. S., & Di, L. (2018). Relevance of Half-Life in Drug Design. Journal of Medicinal Chemistry, 61(10), 4273–4282. https://doi.org/10.1021/acs.jmedchem.7b00969
Smith, D. A., Beaumont, K., Maurer, T. S., & Di, L. (2019). Clearance in drug design. Journal of Medicinal Chemistry, 62(5), 2245–2255. https://doi.org/10.1021/acs.jmedchem.8b01263
Sorkun, M. C., Khetan, A., & Er, S. (2019). AqSolDB, a curated reference set of aqueous solubility and 2D descriptors for a diverse set of compounds. Scientific Data, 6(1), 143. https://doi.org/10.1038/s41597-019-0151-1
Stork, C., Embruch, G., Šícho, M., de Bruyn Kops, C., Chen, Y., Svozil, D., & Kirchmair, J. (2020). NERDD: a web portal providing access to in silico tools for drug discovery. Bioinformatics, 36(4), 1291–1292. https://doi.org/10.1093/bioinformatics/btz695
Susa, S. T., Hussain, A., & Preuss, C. V. (2025). Drug Metabolism. In StatPearls. StatPearls Publishing.
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Rupp, M., Teetz, W., Brandmaier, S., Abdelaziz, A., Prokopenko, V. V., Tanchuk, V. Y., Todeschini, R., Varnek, A., Marcou, G., Ertl, P., Potemkin, V., Grishina, M., Gasteiger, J., Schwab, C., Baskin, I. I., … Tetko, I. V. (2011). Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information. Journal of Computer-Aided Molecular Design, 25(6), 533–554. https://doi.org/10.1007/s10822-011-9440-2
Swanson, K., Walther, P., Leitz, J., Mukherjee, S., Wu, J. C., Shivnaraine, R. V., & Zou, J. (2024). ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics, 40(7). https://doi.org/10.1093/bioinformatics/btae416
Takebe, T., Imai, R., & Ono, S. (2018). The current status of drug discovery and development as originated in united states academia: the influence of industrial and academic collaboration on drug discovery and development. Clinical and Translational Science, 11(6), 597–606. https://doi.org/10.1111/cts.12577
Testa, B., Folkers, G., Kramer, S., & Wunderli-allenspach, H. (2007). Pharmacokinetic Profiling In Drug Research: Biological, Physicochemical, And Computational Strategies. John Wiley & Sons.
Veith, H., Southall, N., Huang, R., James, T., Fayne, D., Artemenko, N., Shen, M., Inglese, J., Austin, C. P., Lloyd, D. G., & Auld, D. S. (2009). Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nature Biotechnology, 27(11), 1050–1055. https://doi.org/10.1038/nbt.1581
Wang, N.-N., Dong, J., Deng, Y.-H., Zhu, M.-F., Wen, M., Yao, Z.-J., Lu, A.-P., Wang, J.-B., & Cao, D.-S. (2016). ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting. Journal of Chemical Information and Modeling, 56(4), 763–773. https://doi.org/10.1021/acs.jcim.5b00642
Wang, S., Sun, H., Liu, H., Li, D., Li, Y., & Hou, T. (2016). ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches. Molecular Pharmaceutics, 13(8), 2855–2866. https://doi.org/10.1021/acs.molpharmaceut.6b00471
Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Tian, Y., Zhang, B., Luo, Y., & Sun, X. (2024). New drug discovery and development from natural products: Advances and strategies. Pharmacology & Therapeutics, 264, 108752. https://doi.org/10.1016/j.pharmthera.2024.108752
Waring, M. J. (2010). Lipophilicity in drug discovery. Expert Opinion on Drug Discovery, 5(3), 235–248. https://doi.org/10.1517/17460441003605098
Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., Djoumbou-Feunang, Y., Greiner, R., & Metz, T. O. (2022). BioTransformer 3.0-a web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123. https://doi.org/10.1093/nar/gkac313
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023). The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduction and Targeted Therapy, 8(1), 217. https://doi.org/10.1038/s41392-023-01481-w
Xu, C., Cheng, F., Chen, L., Du, Z., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2012). In silico prediction of chemical Ames mutagenicity. Journal of Chemical Information and Modeling, 52(11), 2840–2847. https://doi.org/10.1021/ci300400a
Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019). admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35(6), 1067–1069. https://doi.org/10.1093/bioinformatics/bty707
Zaretzki, J., Matlock, M., & Swamidass, S. J. (2013). XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks. Journal of Chemical Information and Modeling, 53(12), 3373–3383. https://doi.org/10.1021/ci400518g
Zdrazil, B., Felix, E., Hunter, F., Manners, E. J., Blackshaw, J., Corbett, S., de Veij, M., Ioannidis, H., Lopez, D. M., Mosquera, J. F., Magarinos, M. P., Bosc, N., Arcila, R., Kizilören, T., Gaulton, A., Bento, A. P., Adasme, M. F., Monecke, P., Landrum, G. A., & Leach, A. R. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Research, 52(D1), D1180–D1192. https://doi.org/10.1093/nar/gkad1004
Zeng, T., Li, J., & Wu, R. (2024). Natural product databases for drug discovery: Features and applications. Pharmaceutical Science Advances, 2, 100050. https://doi.org/10.1016/j.pscia.2024.100050
Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., & Qin, S. (2021). Cytochrome P450 enzymes and drug metabolism in humans. International Journal of Molecular Sciences, 22(23). https://doi.org/10.3390/ijms222312808
http://orcid.org/0000-0003-4444-8221